Clinico-biological trajectories stratified by combined tau biomarkers in preclinical Alzheimer’s disease
Abstract Background Tau pathology biomarkers provide prognostic indicators of neurodegeneration and cognitive decline in Alzheimer’s disease (AD), making them crucial to early patient stratification for disease-modifying interventions. Plasma p-tau217 indexes early tau pathophysiology, whereas FDA/E...
Gardado en:
| Principais autores: | , , , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
BMC
2026-06-01
|
| Series: | Alzheimer’s Research & Therapy |
| Assuntos: | |
| Acceso en liña: | https://doi.org/10.1186/s13195-026-02123-3 |
| Tags: |
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|